These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22074739)

  • 1. Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.
    Kinoshita Y; Kalir T; Rahaman J; Dottino P; Kohtz DS
    Am J Pathol; 2012 Jan; 180(1):375-89. PubMed ID: 22074739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
    Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z
    Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear distributions of NUP62 and NUP214 suggest architectural diversity and spatial patterning among nuclear pore complexes.
    Kinoshita Y; Kalir T; Dottino P; Kohtz DS
    PLoS One; 2012; 7(4):e36137. PubMed ID: 22558357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
    Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
    Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
    Solár P; Sytkowski AJ
    Cancer Lett; 2011 Oct; 309(1):11-8. PubMed ID: 21676537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
    Wang Y; Wang H; Song T; Zou Y; Jiang J; Fang L; Li P
    Mol Med Rep; 2015 Aug; 12(2):2211-6. PubMed ID: 25824616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells.
    Kulshrestha A; Katara GK; Ginter J; Pamarthy S; Ibrahim SA; Jaiswal MK; Sandulescu C; Periakaruppan R; Dolan J; Gilman-Sachs A; Beaman KD
    Mol Oncol; 2016 Jun; 10(6):789-805. PubMed ID: 26899534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
    Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y
    Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.
    Yan XY; Zhang Y; Zhang JJ; Zhang LC; Liu YN; Wu Y; Xue YN; Lu SY; Su J; Sun LK
    Cancer Sci; 2017 Jul; 108(7):1405-1413. PubMed ID: 28498503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].
    Li Z; Wang Q; Zhang W; Yang Z; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):854-60. PubMed ID: 26887775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
    Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
    Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi-mediated knockdown of the CLN3 gene inhibits proliferation and promotes apoptosis in drug-resistant ovarian cancer cells.
    Mao D; Che J; Han S; Zhao H; Zhu Y; Zhu H
    Mol Med Rep; 2015 Nov; 12(5):6635-41. PubMed ID: 26299671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. shRNA-mediated AMBRA1 knockdown reduces the cisplatin-induced autophagy and sensitizes ovarian cancer cells to cisplatin.
    Li X; Zhang L; Yu L; Wei W; Lin X; Hou X; Tian Y
    J Toxicol Sci; 2016 Feb; 41(1):45-53. PubMed ID: 26763392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
    Wan J; Shi F; Xu Z; Zhao M
    Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer.
    Risnayanti C; Jang YS; Lee J; Ahn HJ
    Sci Rep; 2018 May; 8(1):7498. PubMed ID: 29760419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knock-down of superoxide dismutase 1 sensitizes cisplatin-resistant human ovarian cancer cells.
    Kim JW; Sahm H; You J; Wang M
    Anticancer Res; 2010 Jul; 30(7):2577-81. PubMed ID: 20682985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rab25 is responsible for phosphoinositide 3-kinase/AKT‑mediated cisplatin resistance in human epithelial ovarian cancer cells.
    Fan Y; Wang L; Han X; Liu X; Ma H
    Mol Med Rep; 2015 Mar; 11(3):2173-8. PubMed ID: 25405658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of OSBP-related protein 8 (ORP8) modifies the macrophage transcriptome, nucleoporin p62 distribution, and migration capacity.
    Béaslas O; Vihervaara T; Li J; Laurila PP; Yan D; Olkkonen VM
    Exp Cell Res; 2012 Sep; 318(15):1933-45. PubMed ID: 22683860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
    Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
    Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.